MedPath
NMPA Approval

磷酸可待因

国药准字H20067742

December 7, 2020

国药准字H20067742

Drug Information

磷酸可待因

原料药

化学药品

December 7, 2020

Company Information

Manufacturing Company

廊坊经济技术开发区创业路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

磷酸可待因 - NMPA 批准文号 | MedPath